Dr. Sundby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bldg 10
Bethesda, MD 20892Phone+1 301-219-3758Fax+1 301-451-7010
Education & Training
- National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2017
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2021
- University of California San FranciscoPediatrics, Residency, 2014 - 2017
- Vanderbilt University School of MedicineClass of 2014, MD
- Haverford CollegeBS, Biology, 2004 - 2008
Certifications & Licensure
- MD State Medical License 2018 - 2025
- CA State Medical License 2016 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Omolara A. Olaniyan, MD Fellowship Appreciation Award for Teaching and Patient Care John Hopkins, 2018
- Medical Scholar Vanderbilt University, 2012
Publications & Presentations
PubMed
- 1 citationsContemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.Angela C Hirbe, Carina A Dehner, Eva Dombi, Vanessa Eulo, Andrea M Gross
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01 - 4 citationsMEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.Dana C Borcherding, Neha V Amin, Kevin He, Xiaochun Zhang, Yang Lyu
Clinical Cancer Research. 2023-04-14 - 18 citationsUrine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.Pradeep S Chauhan, Alexander Shiang, Irfan Alahi, R Taylor Sundby, Wenjia Feng
NPJ Precision Oncology. 2023-01-19
Abstracts/Posters
- Cell free DNA analysis for early detection of malignant transformation in patients with neurofibromatosis type 1 (NF1)R. Taylor Sundby, MD, Children’s Tumor Foundation NF Conference, Virtual, 2020
- Genetic and epigenetic determinants of breast cancerR. Taylor Sundby, Certificate Program in Molecular Medicine Symposium, Vanderbilt-Ingram Cancer Center Retreat and Medical Scholars Research Day, Nashville, TN, 2013
- Normal human islets form amyloid in vitro and in vivoR. Taylor Sundby, NIDDK Medical Student Research National Symposium, Nashville, TN, 2010
- Join now to see all
Lectures
- Applications of cell free DNA in cancer predisposition (Branch Rounds)National Cancer Institute: Division of Cancer Epidemiology and Genetics, Bethesda, MD - 2020
- Updates on Immune Thrombocytopenic Purpura (Johns Hopkins Pediatric Trends, Invited Speaker)Baltimore, MD - 2019
- Investigative and Clinical Applications of Cell Free DNA (Branch Rounds)National Institute of Diabetes and Kidney Diseases: Metabolic Diseases Branch, Bethesda, MD - 2019
Other Languages
- Spanish
External Links
- Faculty Profilehttps://ccr.cancer.gov/staff-directory/russell-taylor-sundby
- Orcidhttps://orcid.org/0000-0001-8485-0026
- LinkedInhttps://www.linkedin.com/in/russellsundby
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: